Action | Date | Index | Provider |
---|---|---|---|
Join | 2023 | EGX100 EWI | Egyptian Exchange |
Join | 2023 | EGX70 EWI Index | Egyptian Exchange |
Leave | 2023 | EGX 50 EWI | Egyptian Exchange |
Leave | 2023 | EGX100 EWI | Egyptian Exchange |
Leave | 2023 | EGX70 EWI Index | Egyptian Exchange |
Join | 2022 | EGX 50 EWI | Egyptian Exchange |
Join | 2022 | EGX100 EWI | Egyptian Exchange |
Join | 2022 | EGX70 EWI Index | Egyptian Exchange |
Macro Group Pharmaceuticals - Macro Capital S.A.E |
83 Almoltaka Alarabi Street, Sheraton Al Matar, El Nozha, Cairo Governorate |
T : +20 2 2860 6027 |
F : +20 2 2860 6026 |
www.macro-egy.com |
info@macro-egy.com |
Title | Name | As Of |
---|---|---|
Chairman: | Ahmed Nayeb | 2021 |
Board Member: | Sahar El Sallab | 2021 |
Samia El Barody | 2021 | |
Ahmed Badruddin | 2021 | |
Tamer Saeed | 2021 | |
Norbert Lores | 2021 | |
Conor McNeton | 2021 |
Date | Title | File |
---|---|---|
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Non- consolidated Quarterly Financials Report Q3 2024 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Quarterly Financials Report Q3 2024 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Quarterly Financials Report Q2 2024 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Non- consolidated Quarterly Financials Report Q2 2024 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Non- consolidated Quarterly Financials Report Q1 2024 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Quarterly Financials Report Q1 2024 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Annual Financials Report 2023 | |
2024 | Macro Group Pharmaceuticals - Macro Capital S.A.E Non- consolidated Annual Financials Report 2023 | |
2023 | Macro Group Pharmaceuticals - Macro Capital S.A.E Non- consolidated Quarterly Financials Report Q3 2023 | |
2023 | Macro Group Pharmaceuticals - Macro Capital S.A.E Quarterly Financials Report Q3 2023 | |
2023 | Macro Group Pharmaceuticals - Macro Capital S.A.E Non- consolidated Quarterly Financials Report Q2 2023 |